Navigation Links
Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
Date:2/9/2011

ate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "should" and "could," and similar expressions or words identify forward-looking statements. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. The inclusion of forward-looking statements should not be regarded as a representation by Amicus that any of its plans will be achieved. Any or all of the forward-looking statements in this press release may turn out to be wrong. They can be affected by inaccurate assumptions Amicus might make or by known or unknown risks and uncertainties. For example, with respect to statements regarding the goals, progress, timing and outcomes of discussions with regulatory authorities and the potential goals, progress, timing and results of preclinical studies and clinical trials, actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the business of Amicus, including, without limitation: the potential that results of clinical or pre-clinical studies indicate that the product candidates are unsafe or ineffective; the potential that it may be difficult to enroll patients in our clinical trials; the potential that regulatory authorities may not grant or may delay approval for our product candidates; the potential that preclinical and clinical studies could be delayed because we identify serious side effects or other safety issues; the potential that we will need additional funding to complete all of our studies and, our dependence on third parties in the conduct of our clinical studies. Further, the results of earlier preclinical studies and/or clinical trials may not be predictive of future results. In addition, all forward looking statements are subject to other risks detailed in our Annual Report on Form 10-K for the year ended December 31, 2009. You are cautioned not to place undue reliance on these forward
'/>"/>
SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, ... (OTCQX: DMPI) (DelMar and the Company), a company ... in new orphan drug indications, today announced that ... U.S. Patent and Trademark Office (USPTO) for patent ... to improve the therapeutic benefit of suboptimally administered ...
(Date:3/2/2015)... Ohio , March 2, 2015  Sarnova, ... the launch of the new www.tri-anim.com ... full-service, specialty healthcare distributor of respiratory, anesthesia and ... country. The site has many ... overall experience, making online shopping and ordering easier ...
(Date:3/2/2015)... , March 2, 2015  Maquet Medical Systems ... it has signed an exclusive distribution agreement with ... flagship product, the Flight 60 mechanical ventilator. The ... providing dependable and affordable mobility. Starting in the ... be sold in the United States ...
Breaking Medicine Technology:DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3
... Midwest college that is producing alumni with sizeable reputations in ... Lilly Endowment to launch a School of Pharmacy. ... Laureate in chemistry, the inventor of Teflon®, the discoverer of ... of the U.S. Food and Drug Administration among its graduates. ...
... 20, 2010 Varian Medical Systems (NYSE: VAR ... quarter of fiscal year 2011 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ...
Cached Medicine Technology:Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy 2Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy 3Varian Medical Systems Schedules First Quarter FY2011 News Release and Conference Call 2
(Date:3/2/2015)... York (PRWEB) March 02, 2015 Tyrone ... Idoll Magazine, a medium for the model agency industry, ... find, and buy Mango, Passion Fruit, Pink Grapefruit, Pomegranate, ... 3rd, 2015, after 1pm. , At a cost of ... recently came under fire by announcing the brands commitment ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In Construction ... Construction Week (March 1-7, sponsored by the National Association ... History Month, Robins & Morton is recognizing several women ... the construction industry as a whole. From the craft ... roles in between, each woman has a story to ...
(Date:3/2/2015)... Va. (PRWEB) March 02, 2015 The ... nonprofit authority on the use of health IT to ... white paper, “ICD-10 Testing for Small Providers.” The white ... with a starting point for ICD-10 testing by focusing ... payers to ensure compliance with the October 1, 2015 ...
(Date:3/2/2015)... NEW YORK, NY (PRWEB) March 02, 2015 ... kicks off March 2–8 and will provide opportunities for people ... find new ways to help people with MS live their ... recognize progress made and to inspire others to join the ... , Multiple sclerosis, an unpredictable, often disabling disease of the ...
(Date:3/2/2015)... March 02, 2015 Four Seasons Resort Maui ... its 25th anniversary this year, having officially opened its doors ... luxury resort is honoring over 70 employees who started on ... from amongst the approximately 400 original employees. The celebration ... Oceanfront Lawn. , This Four Seasons flagship resort, ...
Breaking Medicine News(10 mins):Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2
... 20 EmPower Research, LLC, a pioneer in,the ... its,first-ever study on the Indian Contract Research Organization ... Contract Research Industry, (CRO-nicles),captures the industry,s current position, ... top line industry executives first hand. India ...
... SAN DIEGO, Oct. 19 Local youth teamed up ... the San Diego,County Alcohol Policy Panel,s annual Legislative Forum ... as distilled spirits and to,investigate the labeling practices of ... enforcement officers and teachers energy drinks, some,with alcohol some ...
... WASHINGTON, Oct. 19 Following is a statement,by ... Healthcare Products,Association (CHPA), regarding the recommendations issued today ... Advisory Committee and,Pediatric Advisory Committee. At a meeting ... over-the-counter cough and cold medicines in children., ...
... Tablets are specially formulated ... for children, ... the safety and efficacy of many name brand,over-the-counter children,s cough and cold ... of their children,s cold and flu,symptoms. Hyland,s, Inc. is pleased to ...
... to State Supreme Court, WILMINGTON, Del., Oct. 19 ... in the Spelter, W.Va., zinc,smelter class action lawsuit. The ... J. Mobley. "We are extremely disappointed by the ... it has been unfairly punished for doing,the right thing ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that ... registration statement with the Securities,and Exchange Commission relating to ... stock. In connection with this offering,Arena plans to grant ... to,an additional 1,500,000 shares of common stock to cover ...
Cached Medicine News:Health News:EmPower Research Launches Indian CRO Industry Report 2Health News:Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks 2Health News:Statement from the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines 2Health News:Hyland's Homeopathic Medicine Offers Parents Safe, All-Natural Option to Alleviate the Symptoms of Colds 2Health News:DuPont Responds to Spelter, W.Va., Lawsuit Decision 2Health News:Arena Pharmaceuticals Announces Public Offering of Common Stock 2
Straight shafts with two point fixation. Tips separated by 3 mm, each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with dull finish....
The Elschnig teeth of this forceps are ideal for grasping sclera during suturing. Delicate tying platform handles the finest suture material. 0.12 mm, 1 x 2 teeth....
Micro pierse type tips with 2 mm angled Colibri style jaws. Flat open serrated handle, dull finish....
Narrow 12 mm jaws with fine teeth. Serrated handle with polished finish....
Medicine Products: